Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Metropolis Healthcare Ltd. Share Price
Day's Range
Day's Range
Low
₹525.05
High
₹537.35
Price Summary
| Previous Close | ₹528.80 |
|---|---|
| Day's Range | ₹525.05 - ₹537.35 |
| Open | ₹525.05 |
| 52 Week Range | ₹400.40 - ₹600.00 |
| Volume | 4,36,186 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2,315.09 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.24 |
| Price/Earning (TTM) | 57.65 |
| TTM EPS (₹) | 9.16 |
| P/E Ratio | 55.84 |
| Book Value(₹) | 7.24 |
| PAT Margin (%) | 10.93 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 17.59 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 13312.03 | 3452.92 |
| Expenses | N/A | N/A |
| PBT | 1908.53 | 360.44 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1455.14 | 292.31 |
About Metropolis Healthcare Ltd.
| Founded | 2000 |
|---|---|
| NSE Symbol | METROPOLIS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,53,750.23 | 1,891.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,82,116.76 | 6,856.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,51,313.88 | 4,474.05 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,19,400.22 | 8,313.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,225.36 | 1,401.65 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,10,037.00 | 1,319.00 | 1,148.40 - 1,148.40 |
| Max Healthcare Institute Ltd. | 1,06,234.43 | 1,091.55 | 903.00 - 903.00 |
| Lupin Ltd. | 1,04,489.83 | 2,287.25 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 1,04,265.97 | 1,036.20 | 835.50 - 835.50 |
| Mankind Pharma Ltd. | 1,03,844.60 | 2,506.70 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Metropolis Healthcare informs about allotment of bonus equity shares
In reference to its previous intimations dated February 04, 2026, March 09, 2026, and March 10, 2026, and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Metropolis Healthcare has informed that the Company has today, on March 23, 2026, allotted 15,54,95,826 equity shares of face value of INR 2/- each as fully paid equity shares, in the ratio of 3:1, i.e., Three new fully paid-up Equity Shares of face value of INR 2/- each for every One existing fully paid-up Equity Share of face value of INR 2/- each, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on March 20, 2026, the ‘Record Date’ fixed for this purpose. Consequent to the aforesaid allotment, paid-up share capital of the Company stands increased to INR 41,46,55,536/- divided into 20,73,27,768 equity shares of face value of INR 2/- each.
The above information is a part of company’s filings submitted to BSE.
Lenskart Solutions informs about outcome of board meeting
Lenskart Solutions informs about press release
Sai Life Sciences informs about earnings call transcript
Kaya informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Metropolis Healthcare Ltd. is ₹528.80 as of 2026-05-21.
The market capitalisation of Metropolis Healthcare Ltd. is ₹10,954.38 as of 2026-05-21.
The 1-year return of Metropolis Healthcare Ltd. is 0.00% as of 2026-05-21.
The P/E ratio of Metropolis Healthcare Ltd. is 55.84 as of 2026-05-22.
The 52-week high and low of Metropolis Healthcare Ltd. are ₹600.00 and ₹400.40, respectively, as of 2026-05-21.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
